Navigation Links
Damon Runyon-Rachleff Innovation Awards granted for pioneering ideas in cancer research
Date:1/7/2013

troducing stable molecules that mimic antibodies (deemed "intrabodies"). He will use this proposed delivery platform to strike the intracellular cancer target Bcr-Abl for treatment of chronic myeloid leukemia. He also aims to target the cancer-promoting complex p53/MDM2 in cancer cells. Through these innovative studies, he aims to advance the frontier by delivering a diverse array of antibody-like molecules into cells for cancer therapy.

Agnel Sfeir, PhD
New York University School of Medicine/Skirball Institute, New York

Each cell contains organelles called mitochondria, which are the powerhouses of cells, producing energy in the form of ATP. Mitochondria contain their own separate DNA, which codes for key energy-producing enzymes. Maintaining the integrity of the mitochondrial genome is necessary for optimal cellular function and for protection against diseases. Alterations in mitochondrial DNA are associated with and can promote metastasis of many tumors, such as lung, breast and prostate. Such aberrations range from single base substitutions to large-scale deletions that remove segments of the mitochondrial genome. The mechanism by which these aberrations influence disease progression remains unclear.

Dr. Sfeir aims to uncover the underlying basis for accumulation of these highly dangerous deletions in mitochondrial DNA and the mechanism by which they shape tumor behavior. This work will help identify novel strategies to preserve mitochondrial function and thwart tumor progression.

Sarah (Sadie) M. Wignall, PhD
Northwestern University, Illinois

Cancer cells exhibit uncontrolled growth and proliferation, leading to the formation of malignant tumors. Therefore, many current cancer therapies are aimed at trying to block cell multiplication, with the goal of killing cancerous cells and halting tumor growth. However, many of these treatments also affect the growth and division of non-cancerous cel
'/>"/>

Contact: Yung S. Lie, Ph.D.
yung.lie@damonrunyon.org
212-455-0521
Damon Runyon Cancer Research Foundation
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. Science means innovation
2. Inventor honored for bridging innovation and humanitarianism to help millions globally
3. Science, Innovation, and Partnerships for Sustainability -- Symposium May 16-18
4. MADRID-MIT M+Vision Consortium hosts Biomedical Innovation Conference 2012
5. NineSigma Launches NineSights, the Worlds First Open Innovation Social Media Destination for Innovation Seekers and Solution Providers
6. ESMO 2012 Congress: A path for medical oncology innovations
7. NSF Leadership in Discovery and Innovation sparks White House US Ignite Initiative
8. Security Technology Executive, SIA and ISC East announce Security Innovation Awards Collaboration
9. New video series highlights the people who fuel Americas innovation pipeline
10. NSF research alliances begin new efforts to accelerate innovation
11. Bacterias key innovation helps understand evolution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... for delivering compounds that could positively impact ... may be possible, thanks to researchers in ... semi-soft vaginal suppository made from the seaweed-derived ... antiviral drug Tenofovir provides a woman-initiated, drug-delivery ... of sexually transmitted infections during unprotected heterosexual ...
(Date:8/28/2014)... August 28, 2014 Dyslexia, the most commonly ... a neurological reading disability that occurs when the ... don,t function normally. , The use of non-invasive ... activity is disrupted in dyslexia. However, most prior ... of brain regions, leaving a gap in our ...
(Date:8/28/2014)... the first person to alert the world to Global ... be captured and stored underground. He says that Carbon ... the best way to avoid global warming getting out ... (Columbia University, New York) made the call during his ... where 150 scientists are meeting to discuss Carbon Capture ...
Breaking Biology News(10 mins):Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 3Dyslexic readers have disrupted network connections in the brain 2Global warming pioneer calls for CO2 to be taken from atmosphere and stored underground 2
... and molecular biologists, chemists, physicists, material scientists, computational modelers ... the newly funded Center for Lignocellulose Structure and Formation, ... Penn State. The DOE plans to fund the ... Cosgrove, professor of biology, will direct the Center in ...
... human brain stores some kinds of memories for a ... at things, our gray matter also creates temporary memories ... seconds these visual memories exist. For decades, scientists have ... grow gradually more imprecise over the course of several ...
... A new longitudinal study of children,s personality traits ... differently in girls and boys. The study, by ... of Hawaii at Manoa, and Purdue University, appears ... Child Development . The researchers looked ...
Cached Biology News:Center to investigate plant cells for better biomass fuels 2Some short-term memories die suddenly, no fading 2Sugar, spice and puppy dog tails: Developing sex-typed personality traits and interests 2
(Date:8/29/2014)... August 29, 2014 Intrinsic Imaging, ... certified, GAMP® 5 compliant imaging core lab, announced ... Phase II clinical trial to assess a new ... this trial, Intrinsic Imaging will provide comprehensive imaging ... protocol and charter development, site qualification, site training ...
(Date:8/28/2014)... “This kit has an improved extraction efficiency and provides users ... said Mark Tess, PhD, Mycotoxin Product Manager for Charm Sciences. ... USDA-GIPSA inspection agencies that have a need to detect aflatoxin ... a matter of minutes with nothing but our equipment and ... grain before accepting it, but they no longer have to ...
(Date:8/28/2014)... Grove, PA (PRWEB) August 28, 2014 ... and create a culture that will allow individuals to ... are becoming increasingly important for employers looking to compete ... science industries are embracing this trend, as the sector ... fabric of a company, which will have real results ...
(Date:8/28/2014)... PARK, Calif. , Aug. 28, 2014 /PRNewswire/ ... focused on developing novel mid- to late-stage cardiovascular ... $7.0 million in its first round of financing. ... Biomedical Investments and Hercules Bioventures with participation from ... entrepreneur and pharmaceutical executive, Dr. Larry Hsu ...
Breaking Biology Technology:Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 3Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 3
... sponges, IUDs, diaphragms-- women have many options for planning their ... men want to help out? They have only two options ... crucial for dating but get old in long-term relationships. ... that nobody is every calling them "Daddy" before they are ...
... PPD, Inc. (Nasdaq:,PPDI) will release its third quarter 2007 ... The earnings release will be available,on the PPD Web ... On Wednesday, October 24, at 9 a.m. ET, ... to discuss financial results and the,overall business environment. A ...
... 28 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, ... interim results from a U.K. Phase Ia/Ib ... with advanced or,metastatic cancers is scheduled to ... (NCRI) conference on October 2, 2007 in ...
Cached Biology Technology:Of mice and men: new male contraceptives successful in rodents and humans 2PPD Announces Third Quarter 2007 Earnings Release, Webcast and Conference Call 2Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 2Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 3Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 4
15(S)-HEDE is produced from 11Z,14Z-eicosadienoic acid by 15-LO. 15(S)-HEDE is an inhibitor of RBL-1 cell 5-LO with an IC50 value of 26 µM....
Mouse monoclonal [HYB 232-02] to Protein S ( Abpromise for all tested applications). entrezGeneID: 5627 SwissProtID: P07225...
Simple operation and an easy-to-read LCD display characterize our Classic Light balances. * Taring range 0...1510 g...
... SLi 3 •3H 2 O Formula Weight: 881.42 ... pH 7.0): greater than or equal to 90% lambda max : 259 ... Spectral Ratios: A 232 /A 260 : 0.51 ... 280 /A 260 : 0.17 0.02 Storage: -20C ...
Biology Products: